CCRM
Michael Israels is a seasoned finance professional with extensive experience in leadership roles within the regenerative medicine and asset management sectors. Currently serving as Chief Financial Officer at the Centre for Commercialization of Regenerative Medicine (CCRM) since November 2013, Michael also holds directorships at OmniaBio, CCRM Australia, and the Canadian Advanced Therapies Training Institute (CATTI) Inc. Prior experience includes serving as CFO at ExCellThera Inc. and leading asset management advisory services at Ernst & Young. Michael's educational background includes an Honors degree in Business Administration from Ivey Business School at Western University, along with professional designations as a Chartered Professional Accountant and Chartered Business Valuator.